Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002024 · ClinicalTrials.gov registry record · NA
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
A NA study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- NA
- Development phase
NCT00002024: Completed NA study, sponsored by Hoffmann-La Roche.
NCT00002024 is a NA study that has completed, run by Hoffmann-La Roche. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002024, a NA study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To provide ganciclovir on a compassionate use basis to immunocompromised patients with serious cytomegalovirus (CMV) infections and to study safety and efficacy in this patient population.
Interventions
- DRUG Ganciclovir
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002024 record still lists
NCT00002024 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Ganciclovir is the first listed.
NCT00002024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002024 about?
NCT00002024 is a clinical study titled "Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections". To provide ganciclovir on a compassionate use basis to immunocompromised patients with serious cytomegalovirus (CMV) infections and to study safety and efficacy in this patient population.
What is the current status of trial NCT00002024?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002024?
The interventions under investigation include: Ganciclovir (DRUG).
Who is sponsoring clinical trial NCT00002024?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.